SEC Form 3 · accession 0001437749-18-008157
Tapinator, Inc. · TAPM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Teymour M Farman-Farmaian
Director
Period of report
Apr 30, 2018
Accepted (ET)
Apr 30, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001647170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $0.33 | holding | — | — | — | — | Jan 29, 2026 | Common Stock | 300,000 | — | D |
| Options to Purchase Common StockF2 | $0.11 | holding | — | — | — | — | May 11, 2027 | Common Stock | 250,000 | — | D |
| Restricted Stock UnitF3 | $0.00 | holding | — | — | — | — | — | Common Stock | 250,000 | — | D |
Explanation of responses
- F1This grant began vesting on March 31, 2016 and shall continue to become exercisable ratably in quarterly installments over the next two years thereafter at an exercise price of $0.33. The Reporting Person must be a member of the Board of Directors as of each vesting date.
- F2This grant began vesting on June 30, 2017 and shall continue to become exercisable ratably in quarterly installments over the next three years thereafter at an exercise price of $0.11. The Reporting Person must be a member of the Board of Directors as of each vesting date.
- F3This grant will begin vesting on August 21, 2019 and will vest ratably in monthly installments over the next eighteen months thereafter. The Reporting Person must be a member of the Board of Directors as of each vesting date.
Remarks
The Reporting Person has elected to begin making Section 16 filings as of the date hereof and in connection with the filing of a registration statement on Form S-1 by the Issuer as of the date hereof.